PROCEEDINGS OF SPIE. Event: SPIE BiOS, 2008, San Jose, California, United States

Transcription

1 PROCEEDINGS OF SPIE SPIEDigitalLibrary.org/conference-proceedings-of-spie Front Matter: Volume 6846, "Front Matter: Volume 6846," Proc. SPIE 6846, Mechanisms for Low-Light Therapy III, (27 February 2008); doi: / Event: SPIE BiOS, 2008, San Jose, California, United States

2 PROGRESS IN BIOMEDICAL OPTICS AND IMAGING Vol. 9, No. 5 Mechanisms for Low-Light Therapy III Michael R. Hamblin Ronald W. Waynant Juanita Anders Editors 20 January 2008 San Jose, California, USA Sponsored and Published by SPIE Volume 6846 Proceedings of SPIE, , v SPIE is an international society advancing an interdisciplinary approach to the science and application of light.

3 The papers included in this volume were part of the technical conference cited on the cover and title page. Papers were selected and subject to review by the editors and conference program committee. Some conference presentations may not be available for publication. The papers published in these proceedings reflect the work and thoughts of the authors and are published herein as submitted. The publisher is not responsible for the validity of the information or for any outcomes resulting from reliance thereon. Please use the following format to cite material from this book: Author(s), "Title of Paper," in Mechanisms for Low-Light Therapy III, edited by Michael R. Hamblin, Ronald W. Waynant, Juanita Anders, Proceedings of SPIE Vol (SPIE, Bellingham, WA, 2008) Article CID Number. ISSN ISBN Published by SPIE P.O. Box 10, Bellingham, Washington USA Telephone (Pacific Time) Fax SPIE.org Copyright 2008, Society of Photo-Optical Instrumentation Engineers. Copying of material in this book for internal or personal use, or for the internal or personal use of specific clients, beyond the fair use provisions granted by the U.S. Copyright Law is authorized by SPIE subject to payment of copying fees. The Transactional Reporting Service base fee for this volume is $18.00 per article (or portion thereof), which should be paid directly to the Copyright Clearance Center (CCC), 222 Rosewood Drive, Danvers, MA Payment may also be made electronically through CCC Online at copyright.com. Other copying for republication, resale, advertising or promotion, or any form of systematic or multiple reproduction of any material in this book is prohibited except with permission in writing from the publisher. The CCC fee code is /08/$ Printed in the United States of America. Publication of record for individual papers is online in the SPIE Digital Library. SPIEDigitalLibrary.org Paper Numbering: Proceedings of SPIE follow an e-first publication model, with papers published first online and then in print and on CD-ROM. Papers are published as they are submitted and meet publication criteria. A unique, consistent, permanent citation identifier (CID) number is assigned to each article at the time of the first publication. Utilization of CIDs allows articles to be fully citable as soon they are published online, and connects the same identifier to all online, print, and electronic versions of the publication. SPIE uses a six-digit CID article numbering system in which: The first four digits correspond to the SPIE volume number. The last two digits indicate publication order within the volume using a Base 36 numbering system employing both numerals and letters. These two-number sets start with 00, 01, 02, 03, 04, 05, 06, 07, 08, 09, 0A, 0B 0Z, followed by 10-1Z, 20-2Z, etc. The CID number appears on each page of the manuscript. The complete citation is used on the first page, and an abbreviated version on subsequent pages. Numbers in the index correspond to the last two digits of the six-digit CID number.

4 Contents v Conference Committee SESSION 1 REVIEWS AND DOSIMETRY The role of nitric oxide in low level light therapy (Invited Paper) [ ] M. R. Hamblin, Wellman Ctr. for Photomedicine, Massachusetts General Hospital (USA) and Harvard Medical School (USA) and Harvard-MIT Division of Health Sciences and Technology (USA) A 3D dose model for low level laser/led therapy biostimulation and bioinhibition [ ] J. D. Carroll, THOR Photomedicine Ltd (United Kingdom) How phototherapy affects the immune system [ ] M. Dyson, King's College London (United Kingdom) and Univ. of London (United Kingdom) The irradiation parameters investigation of photodynamic therapy on yeast cells [ ] R. A. Prates, IPEN-CNEN/SP (Brazil); E. G. da Silva, ICB/USP (Brazil); A. M. Yamada, Jr., L. C. Suzuki, IPEN-CNEN/SP (Brazil); C. R. Paula, ICB/USP (Brazil); M. S. Ribeiro, IPEN-CNEN/SP (Brazil) SESSION 2 IN VITRO Laser light induced modulations in metabolic activities in human brain cancer (Invited Paper) [ ] D. B. Tata, R. W. Waynant, U.S. Food and Drug Administration (USA) Methylene blue aggregation in the presence of human saliva [ ] S. C. Núñez, A. S. Garcez, L. Gomes, IPEN/CNEN-SP (Brazil); M. S. Baptista, Univ. de São Paulo (Brazil); M. S. Ribeiro, IPEN/CNEN-SP (Brazil) A Influence of the fractioned irradiation energy in the phototherapy with low intensity laser on the growth of human dental pulp fibroblasts [ ] D. T. Meneguzzo, C. P. Eduardo, Univ. of Sao Paulo School of Dentistry (Brazil); M. S. Ribeiro, IPEN-CNEN (Brazil); M. M. Marques, Univ. of Sao Paulo School of Dentistry (Brazil) SESSION 3 IN VIVO D Angiogenesis induced by low-intensity laser therapy: comparative study between single and fractioned dose on burn healing [ ] S. T. Sugayama, G. E. C. Nogueira, IPEN-CNEN/SP (Brazil); C. M. França, UNIB (Brazil); R. A. Prates, D. F. T. Silva, S. C. Núñez, M. S. Ribeiro, IPEN-CNEN/SP (Brazil) iii

5 6846 0E Analgesic effect of simultaneous exposure to infrared laser radiation and µt magnetic field in rats [ ] G. Cieslar, J. Mrowiec, S. Kasperczyk, K. Sieron-Stoltny, A. Sieron, Medical Univ. of Silesia (Poland) F Photosensitization of Aggregatibacter actinomycetemcomitans with methylene blue: a microbiological and spectroscopic study [ ] A. M. Yamada, Jr., R. A. Prates, IPEN/CNEN-SP (Brazil); S. Cai, Univ. de São Paulo (Brazil); M. S. Ribeiro, IPEN/CNEN-SP (Brazil) G Antimicrobial comparison on effectiveness of endodontic therapy and endodontic therapy combined with photo-disinfection on patients with periapical lesion: a 6 month follow-up [ ] A. S. Garcez, S. C. Núñez, IPEN/CNEN/SP (Brazil); M. R. Hamblin, Wellman Ctr. for Photomedicine, Massachusetts General Hospital (USA); M. S. Ribeiro, IPEN/CNEN/SP (Brazil) SESSION 4 CLINICAL H Optical coherence tomography imaging for evaluating the photo biomodulation effects on tissue regeneration in the oral cavity [ ] C. B. Gimbel, Lantis Laser Inc. (USA) I The oral cavity as a guide for the application of low level laser energy and its direct effect on the autonomic nervous system providing true energy healing for all health practitioners [ ] H. S. Yolin, Northeast Dental Associates (USA) and Professional Growth Technologies (USA) L Treating cerebral palsy with aculaser therapy [ ] S. Anwar, Anwar Shah Trust for C.P. & Paralysis (Pakistan); M. M. Nazir Khan, M. M. Nadeem Khan, Children's Hospital & Institute of Child Health (Pakistan); F. M. Qazi, A. H. Awan, Anwar Shah Trust for C.P. & Paralysis (Pakistan); I. Dar, Mayo Hospital (Pakistan) Author Index iv

6 Conference Committee Symposium Chairs James Fujimoto, Massachusetts Institute of Technology (USA) R. Rox Anderson, Wellman Center for Photomedicine, Massachusetts General Hospital (USA) and Harvard School of Medicine (USA) Program Track Chair Reza S. Malek, Mayo Clinic (USA) Conference Chairs Michael R. Hamblin, Massachusetts General Hospital (USA) Ronald W. Waynant, U.S. Food and Drug Administration (USA) Juanita Anders, Uniformed Services University of the Health Sciences (USA) Program Committee Stuart K. Bisland, Princess Margaret Hospital (Canada) James D. Carroll, THOR International, Ltd. (United Kingdom) Mary Dyson, Dyderm Ltd. (United Kingdom) Valentin M. Grimblatov, Columbia University Medical Center (USA) Session Chairs 1 Reviews and Dosimetry Darrell B. Tata, U.S. Food and Drug Administration (USA) 2 In Vitro Juanita Anders, Uniformed Services University of the Health Sciences (USA) 3 In Vivo Michael R. Hamblin, Massachusetts General Hospital (USA) 4 Clinical James D. Carroll, THOR International, Ltd. (United Kingdom) v

7